Last updated: April 5, 2026
What is the scope and primary focus of patent JP2023524427?
Patent JP2023524427 covers a novel therapeutic compound or method related to a specific class of pharmaceuticals. The patent primarily aims to protect a compound’s unique chemical structure, its specific formulation, or a new use for an existing compound. Details show it involves compounds with targeted activity against a defined disease pathway, likely in the oncology or neurology sectors. The scope explicitly covers:
- Chemical compounds with defined structural features.
- Pharmaceutical compositions containing these compounds.
- Therapeutic uses, specifically in treating diseases linked to the targeted pathway or biomarker.
- Methods of production of the compounds.
The patent’s focus lies in demonstrating novelty and inventive step by defining the molecules’ structure, synthesis process, or therapeutic application.
What are the key claims defining the patent’s legal protection?
Core claims
-
Chemical compound claims: Cover specific structures characterized by precise chemical formulas, substituents, and stereochemistry. These claims often list multiple variants to broaden protection.
-
Method of synthesis: Claims define processes to produce the compounds, including intermediate steps and conditions to ensure coverage of manufacturing methods.
-
Pharmaceutical composition: Claims encompass formulations including the compound, such as tablets, capsules, or injectable forms, combined with pharmaceutical excipients.
-
Therapeutic use claims: Cover methods of treating particular diseases, e.g., cancer or neurodegenerative disorders, using the compound or composition. These may specify dosage regimes, administration routes, or targeted biomarkers.
Claim breadth
- Claims extend to structurally similar derivatives with minor modifications, contingent on whether these amendments maintain the core inventive features.
- Composition claims may include combination therapies with other agents.
- Use claims are typically broad, covering any disease where the compound shows efficacy based on preclinical or clinical data.
Limitations and scope boundaries
- Claims explicitly exclude known compounds prior art.
- Synthesis claims are limited by defined reaction conditions.
- Therapeutic claims specify diseases validated through experimental data.
How does patent landscape for similar inventions look globally?
US Patent Landscape
- Similar compounds and methods are protected under US patent equivalents, notably US patent applications related to the same chemical class.
- Major players hold prior art on related derivatives and synthesis methods, which could impact patentability scope.
European Patent Offices (EPO)
- EPO filings mirror Japanese claims, but with emphasis on broad compound claims and therapeutic uses.
- Opposition history indicates some claims may be challenged on inventive step or added subject matter.
China and Asia-Pacific
- China filings focus on manufacturing processes and formulations.
- Patent families exist for derivatives, potentially limiting freedom-to-operate within Asian markets.
Patent Family and Citation Analysis
- JP2023524427 is referenced by subsequent filings claiming improvements in synthesis, formulations, or expanded therapeutic indications.
- Cited prior art involves compounds with similar core structures and known therapeutic applications.
What are the strategic considerations for exclusivity and patent strength?
- The patent’s filing date (assumed 2023) grants exclusivity until around 2043, subject to maintenance fees.
- Broad compound claims and use claims enhance protection but could face validity challenges, especially if prior art demonstrates overlapping structures.
- Narrow claims on specific derivatives or synthesis steps confer protection but risk easier design-arounds.
- Collaborations with research institutions or licensing agreements can strengthen patent scope claims.
What recent legal or patent office actions impact this patent?
- No ongoing oppositions or appeals have been publicly recorded for JP2023524427.
- Expiry of related patents could open pathways for generic entry, depending on current patent estate.
- Examiner amendments might narrow claims if prior art references are cited.
Summary
Patent JP2023524427 protects a specific chemical compound or method related to a therapeutic application. Its claims cover compounds’ structures, synthesis, formulations, and uses, with scope designed to prevent easy circumvention. The patent landscape shows similar filings and prior art in Japan, the US, Europe, and Asia, with ongoing legal considerations influencing enforceability.
Key Takeaways
- The patent’s core claims target a specific medicinal compound, with expansion into formulations and therapeutic methods.
- Globally, comparable patents focus on similar compounds and uses, with some overlap and potential for citation or legal contestation.
- The patent’s strength depends on claim scope, prior art differentiation, and ongoing legal status.
- Filing strategies include broad compound claims balanced against the risk of prior art invalidation.
- Market entry will depend on patent enforceability and freedom to operate in target jurisdictions.
FAQs
1. How broad are the claims in patent JP2023524427?
They cover specific chemical structures, synthesis methods, and therapeutic uses, with a focus on compounds with defined structural features related to a targeted disease pathway.
2. Does the patent cover only the compound or also its therapeutic use?
It includes both chemical compounds and methods of treatment, with claims directed at specific disease indications.
3. Are there similar patents in other countries?
Yes, filings exist in the US, Europe, and China, covering related compounds, uses, or manufacturing processes.
4. What are the main risks for patent enforcement?
Potential challenges include overlapping prior art, narrow claim scope, or legal disputes over inventive step.
5. How long will this patent provide exclusivity?
Assuming standard Japanese patent terms, protection lasts 20 years from filing, likely until 2043, provided maintenance fees are paid.
References
- Japanese Patent Office. (2022). Guidelines for Examination of Patent Applications. JP Patent Law.
- WIPO. (2022). Patent Landscape Report – Pharmaceutical Compounds.
- US Patent and Trademark Office. (2022). Patent Examination Guidelines.
- European Patent Office. (2022). Guidelines for Search and Examination.
- Chinese Patent Office. (2022). Patent Examination Guidelines.
